BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.0969
+0.0094 (10.74%)
At close: Sep 8, 2026
BioLargo Revenue
BioLargo had revenue of $1.25M in the quarter ending June 30, 2026, a decrease of -55.06%. This brings the company's revenue in the last twelve months to $4.08M, down -70.95% year-over-year. In the year 2025, BioLargo had annual revenue of $7.77M, down -56.32%.
Revenue (ttm)
4.08M
Revenue Growth
-70.95%
P/S Ratio
7.80
Revenue / Employee
90.71K
Employees
46
Market Cap
31.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.77M | -10.01M | -56.32% |
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Venator Materials | 1.56B |
| TOR Minerals International | 39.43M |
| Greystone Logistics | 27.54M |
| Rubber Leaf | 10.94M |
| Avoca LLC | 5.02M |
| Nocopi Technologies | 2.01M |
| Sincerity Applied Materials Holdings | 32.39K |
BioLargo News
- 5 days ago - BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout - TheFly
- 5 days ago - BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution - Accesswire
- 7 days ago - BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026 - Accesswire
- 14 days ago - BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York - Accesswire
- 15 days ago - Gabelli To Host 4th Annual PFAS Symposium - GlobeNewsWire
- 22 days ago - BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54% - Accesswire
- 25 days ago - BioLargo Quarterly report: Q2 2026 - Filings
- 25 days ago - BioLargo Earnings release: Q2 2026 - Filings